Xtrackers Nifty 500 India ETF IND
22.25 USD +0.53 (+2.42%)
Nov 3, 2026, 1:10 PM EST
22.04 Day range 22.23
20.52 52-week range 27.40
- YTD
- -10.73%
- 1 year
- -11.73%
- Market cap
- 4.43M
- EPS (ttm)
- 1.01
- P/E ratio
- 21.82
- YTD return
- -10.73%
- 1-year return
- -11.73%
- Volume
- 37
- Avg volume
- 646
- Open
- 22.15
- Previous close
- 21.72
- Day's range
- 22.04 – 22.23
- 52-week range
- 20.52 – 27.40
2Y -3.06 (-12.14%)
News
Two Former Moderna Cancer Vaccine Scientists Join Everest Medicines, Accelerating Global Development of Its mRNA Platform 
AARD DEADLINE NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 
AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class Action 
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline 
Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 Deadline 
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline 
Deadline Approaching: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith 
Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit 
Deadline Soon: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit 
AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026
Your note
Sign in to keep a note on IND — it syncs with the Stock Master app.